Lupus Capital PLC
16 February 2004
Result of EGM
A meeting of shareholders held earlier today approved a resolution concerning
the subscription by Greg Hutchings for 17,283,944 Ordinary Shares, employee
incentive arrangements and changes in share capital (including an authority to
buy its own shares in the market) and related matters which were described in
the circular dated 21 January 2004. At the meeting Konrad Legg, the chairman,
noted that the the share price and trading volumes had responded favourably to
the announcement of the proposals and that the average share price over that
period was 14.1p. Shareholders have had opportunities to dispose of some or all
of their shares if they so desired over a period of four weeks at prices
significantly in excess of the price before announcement. Accordingly, the board
is satisfied that a tender facility at 9p would serve no purpose and will not
proceed with the arrangements.
Following the meeting Mr Hutchings joined the board as executive chairman and
Konrad Legg became senior non-executive director.
It is expected that dealings in the Ordinary Shares to be issued under the
subscription will start on 17 February 2004, at which time the Company will have
190,157,029 Ordinary Shares in issue.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.